Foresight Science & Technology

Foresight Science & Technology, Inc. is a scientific consulting firm in Massachusetts offering market research, technology assessment, and valuation and licensing services to the medical, pharmaceutical and biotechnology industries. We specialize in moving technology from the lab into the marketplace.

Foresight assesses approximately 300 new technologies a year, and some of the more notable include: Method and technology for mass spectrometry of proteins and nucleotides; Selective protein purification with minimal denaturation; Single vector, dual gene therapy for pulmonary hypertension; Temperature gradient capillary electrophoresis for mutation detection; Recombinant gene construct for treatment of osteopenias; and more. Current projects include work for Harvard Medical School, the Edison BioTechnology Center, and the Centers for Disease Control and Prevention; customers also include the federal government, Fortune 500 firms, and individual inventors.

Activity:

- Licensing & Business Development
- Market Research & Marketing

Product / Technology type(s) covered:

- Bio
- Devices
- Drug delivery
- Enzymes
- Generics
- Pharmaceuticals / Therapeutics
- Phyto
- Nutritionals / Vitamins
- Proteins
- Reagents
- Technology

Therapeutic targets:

- Arthritis / Rheumato
- Cancer
- Cardiovascular
- Dermatology
- Diabetes
- Epidemiology
- Genetics
- Hematology
- Infectious Diseases
- Oncology
- Orthopedics
- Radiology

Markets Covered

a. HeadQuarter: United States of America

b. Continent(s) active: North America

c. Countries active: United States of America, Canada

Corporate data:

Number of Employees: 23

Turnover:

Amount:	Year:	Currency:
$800,000	2001	US Dollar

Year founded: 1982